About Filip Pinter
Form D filings for BioNADrx in 2024 list Filip Pinter as chief financial officer and a director.
Filip Pinter first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Filip Pinter in the role, so the role may have started earlier or lasted longer.
BioNADrx Holdings, Inc.
Chief Financial Officer and A Director
2024 · Johnson City, TN
Develops oral programs using molecules found in the body.
Key Colleagues at Startups
The people Filip Pinter works with at each company, as listed on that company's latest Form D.
BioNADrx Holdings, Inc. · Form D, Jan 30, 2024
PM
Phillip Mansour
Director
WK
Wendy Kormac
Chief Executive Officer and A Director